-Newsclick.in The sharp and apparently intriguing fall in industrial production in October, and feeble post-Covid recovery, points to a deep-rooted malaise in the Indian economy. There has been much discussion in public about the index of industrial production (IIP) for October 2022 being 4% lower than the index for October 2021; and quite rightly so, since no obvious explanations like a Covid-induced lockdown or even its residual lingering effects can be adduced...
More »SEARCH RESULT
The need to make cancer drugs affordable -Biswajit Dhar and Chetali Rao
-The Hindu With the Rajya Sabha Standing Committee on Health expressing concern over the high cost of cancer treatment, the Government invoking Section 100 of the Patents Act is a way forward The subject of the spiralling costs of cancer medicines and their implications that have frequently been highlighted the world over were dwelled on in a recent report (“Cancer Care Plan and Management”) by the Rajya Sabha’s Standing Committee on Health....
More »Teacher shortage in Jharkhand schools, most pupils have forgotten how to read and write, post-Covid survey shows
Jharkhand's government schools have a massive teacher shortage, a survey by Gyan Vigyan Samiti Jharkhand has found. The survey was conducted in 138 primary and upper primary schools between September and October 2022 to assess their condition after the Covid-19 pandemic. Jharkhand's school system was shut for two years, among the longest in the world. Teachers told the surveyors they felt that most students had forgotten how to read and...
More »Climate change induced extreme events are playing havoc with human lives & livelihoods, show latest available data
It is evident from various studies (please click here, here and here to access) that emission of Greenhouse Gases (GHGs) by the developed as well as the developing countries is responsible for climate change, thus causing extreme weather events to occur, with much more ferocity than in the past. The negative impact of climate change may or may not be felt in the geographical location where historically emission has taken...
More »Price cut on TB drug to expand access
-The Hindu Business Line Agreement between Viatris, MedAccess and TBA to slash cost by 34 per cent on pretomanid A new agreement among drugmaker Viatris, MedAccess, and TB Alliance looks to reduce the price of pretomanid, a drug used to treat multidrug-resistant tuberculosis, by 34 per cent. The agreement will help expand access to this critical new treatment in more than 140 countries, including those with the highest TB burden, said a joint...
More »